Infection Testing
Cryptococcus Quantitative Test
The Cryptococcus Quantitative Test detects the Cryptococcus neoformans fungus, crucial for diagnosing infections, especially in immunocompromised individuals. This test helps guide treatment decisions.
General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.
Review status: No completed medical review is recorded for this page.
At a glance
Plan your test
- Sample
- Fresh tissue biopsy specimens, skin biopsy specimens, tissue specimens (brain, skin, soft tissue, eye, bone, lung, cardiac valve, bone marrow), peripheral blood specimens, or respiratory secretions.
- Results
- Results are typically available within 48 hours via email and 36 hours over the phone. Confirm with the laboratory before booking.
- Preparation
- Patients need to sign a consent document and bring any relevant clinical history related to their health condition before the test.
Payment: M-Pesa and card options can be confirmed during booking.
Insurance & government schemes
Is this test covered for you?
We help you verify whether the Cryptococcus Quantitative Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.
Providers & schemes we can help you check
Government & public schemes
Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.
Private insurers & employer schemes
Names shown for identification only — listing does not imply partnership or guarantee of coverage.
Have these ready when we check
- Insurer or scheme name & policy / member number
- A clinician's request / prescription for the test
- Pre-authorisation letter, if your plan requires one
Free coverage check
Ask us to verify your cover
Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.
Start with fit
Is this the right test for you?
The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.
- ✓Patients with symptoms suggestive of cryptococcal infection (e.g., fever, cough, difficulty breathing).
- ✓Individuals with weakened immune systems, especially those with HIV/AIDS.
- ✓Patients presenting with neurological symptoms.
- ✓Patients with skin lesions potentially related to disseminated infection.
- ✓Monitoring response to antifungal therapy.
In plain language
What this test helps you understand
This test quantitatively measures the levels of Cryptococcus neoformans in various sample types, including fresh tissue biopsy specimens, skin biopsy specimens from patients with disseminated nodular skin lesions, tissue specimens from various body sites (brain, skin, soft tissue, eye, bone, lung, cardiac valve, and bone marrow), peripheral blood specimens, and respiratory secretions.
Medical review status
Clinical review pending
A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.
Meet the DNA Labs Kenya medical team →A simple process
What happens next?
You do not have to navigate the test alone. We help you move from question to next step.
Speak with us
We check the test and answer your questions before collection.
Give your sample
Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.
Understand your report
A counselor helps you understand the result and the next steps.
Choose your collection
Home collection or a lab visit
We will explain the sample, preparation, and next steps before anything is collected.
Home collection
Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.
Lab or hub visit
Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.
Ask about locations →Read your report
What common result terms mean
Questions people ask
Frequently asked questions
Collaboration
Open for partnership with hospitals, clinics, doctors & researchers
Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.
Hospitals & clinics
Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.
Doctors & specialists
LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.
Research institutions
Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.
Students & academic projects
Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.
Trust & transparency
Sources, standards & how this page is maintained
Standards & references
- ACMG/AMP technical standards for sequence variant interpretation
- ClinGen curation and gene–disease validity frameworks where applicable
- LOINC-coded reporting for interoperable results
- ISO 9001:2015 quality management; ISO 15189 accreditation in progress
Page provenance
- Last updated: September 27, 2026
- Medical review: not yet completed
- Written for patients & clinicians in Kenya; reviewed periodically against current guidance
Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.
Keep exploring
Related tests
1 3BetaDGlucan BDG Test
The 1 3BetaDGlucan BDG Test helps detect fungal infections by measuring beta-glucan levels in the blood. It is particularly useful for individuals with weakened immune systems or symptoms suggesting a fungal infection.
Learn more →Chlamydia IgG Antibody Panel Test
Detects past exposure to Chlamydia trachomatis and Chlamydophila pneumoniae infections by measuring IgG antibodies in the blood. Helps identify potential health risks.
Learn more →Dengue Fever IgG Antibody Test
The Dengue Fever IgG Antibody Test detects antibodies indicating a past dengue virus infection. It helps assess immunity and understand previous exposure.
Learn more →Chlamydophila Pneumoniae IgG Test
This test detects IgG antibodies to Chlamydophila pneumoniae, indicating a past infection with this bacterium, which can cause respiratory illnesses.
Learn more →